High levels of topoisomerase IIα protein expression in diffuse large B-cell lymphoma are associated with high proliferation, germinal center immunophenotype, and response to treatment-Reference-Cited by-同舟云学术

High levels of topoisomerase IIα protein expression in diffuse large B-cell lymphoma are associated with high proliferation, germinal center immunophenotype, and response to treatment

Published:2010-05-24 Issue:7 Volume:51 Page:1260-1268
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Pentheroudakis George,Goussia Anna,Voulgaris Evangelos,Nikolaidis Konstantinos,Ioannidou Evaggelia,Papoudou-Bai Alexandra,Grepi Konstantina,Kanavaros Panagiotis,Pavlidis Nicholas,Bai Maria

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2010.483749

Reference43 articles.

1. Human Topoisomerase II Function, Tyrosine Phosphorylation and Cell Cycle Checkpoints

2. DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGS

3. Antitopoisomerase drug action and resistance

4. DNA Topoisomerase II as a Target for Cancer Chemotherapy

5. The Efficacy of Topoisomerase II-Targeted Anticancer Agents Reflects the Persistence of Drug-Induced Cleavage Complexes in Cells

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive value of topoisomerase IIα immunoreactivity in canine diffuse large B-cell lymphoma (DLBCL) and peripheral T-cell lymphoma (PTCL) treated with a doxorubicin-based chemotherapy protocol;Medycyna Weterynaryjna;2023

2. Evaluation of the Proliferative Activity of Diffuse Large B-Cell Lymphoma (DLBCL) in Dogs with Respect to Patient Eligibility for Anthracycline-Based Chemotherapy;Animals;2021-04-20

3. Study of DNA topoisomerase IIa expression in canine lymphomas and its potential role as a marker of sensitivity to anthracycline-based chemotherapy in dogs;Folia Histochemica et Cytobiologica;2020-04-09

4. A systems medicine approach for finding target proteins affecting treatment outcomes in patients with non-Hodgkin lymphoma;PLOS ONE;2017-09-11

5. Targeting nucleolin for better survival in diffuse large B-cell lymphoma;Leukemia;2017-07-10